What's Driving the Immunosuppressant Drugs Market Trends? Genzyme, Astellas Pharma, Accord Healthcare, Bristol-Myers Squibb, GlaxoSmithKline & Glenmark Pharmaceuticals
Immunosuppressant Drugs Market (Drug Type - Calcineurin Inhibitors, Center for Biotechnology, Antiproliferative Agents, Imdh Inhibitors, and Other Drug Types; Route of Administration - Intravenous, Oral, and Other Routes; Application - Organ Transplant, Autoimmune Disease, Kidney Transplant, Liver Transplant, Heart Transplant, and Other Applications; End-user - Organ Transplant Centers, Hospitals and Clinics, and Other End-users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025. The global immunosuppressant drugs market is projected to grow at a CAGR of 4.9% over the...
View full press release